Sanofi SA SNYNF
News
Windward Bio Group IPO of 10.3M Shares Prices at $17 Each
Nurix Therapeutics Shares Plunge on Sanofi's Termination of Drug Development Program
Regeneron Pharma 3Q Sales Climb on Dupixent Growth
Sanofi CEO Sets Sights on Deals to Drive Turnaround — 2nd Update
Sanofi CEO Sets Sights on Deals to Drive Turnaround — Update
Sanofi CEO Sets Sights on Deals to Drive Turnaround
EU Accepts Sanofi's Concessions to End Antitrust Probe Over Vaccine Marketing — Update
EU Accepts Sanofi's Concessions to Settle Antitrust Probe Over Vaccine Marketing
Flu season is already here. Here's what to know about this year's flu shots.
Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal — Update
Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion
European Pharma Leaders Push for National Reforms to Boost Investment
Sanofi to Take Stake in Cheplapharm in Swap for Drug Portfolio, Manufacturing Sites
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
Sanofi Shares Slide After CEO Signals Challenges to Fill Drug Pipeline
Sanofi Raises Guidance as New CEO Looks to Revamp Drug Pipeline
Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
Scribe Therapeutics to Sell 7.15 Million Shares at $13-$15 Each in IPO
EU Seeks Views on Sanofi's Concessions to End Competition Probe — Update

